Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) is a company emerging as a recognizable name within the cannabis space occupied by companies like GW Pharmaceuticals PLC (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Insys Therapeutics, Inc. (NASDAQ: INSY) and Axim Biotechnologies Inc. (OTCQB: AXIM). As quoted in the article: Because the cannabis-biotech sub-sector remains in relative infancy, it is full of uncharted territory and …
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) is a company emerging as a recognizable name within the cannabis space occupied by companies like GW Pharmaceuticals PLC (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Insys Therapeutics, Inc. (NASDAQ: INSY) and Axim Biotechnologies Inc. (OTCQB: AXIM).
As quoted in the article:
Because the cannabis-biotech sub-sector remains in relative infancy, it is full of uncharted territory and prospects as companies aggressively explore the medicinal potential of marijuana and the plant’s compounds and applications. Food bioscience company Lexaria Bioscience Corporation, for instance, enjoys a unique position in this sub-sector.
Read full article here
Click here to connect with Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) to receive an Investor Presentation.
Source: www.networknewswire.com
The Conversation (0)
Latest News
Outlook Reports world
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES